1. Home
  2. ECOR vs MAXN Comparison

ECOR vs MAXN Comparison

Compare ECOR & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • MAXN
  • Stock Information
  • Founded
  • ECOR 2005
  • MAXN 2019
  • Country
  • ECOR United States
  • MAXN Singapore
  • Employees
  • ECOR N/A
  • MAXN N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MAXN Semiconductors
  • Sector
  • ECOR Health Care
  • MAXN Technology
  • Exchange
  • ECOR Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ECOR 57.5M
  • MAXN 61.7M
  • IPO Year
  • ECOR 2018
  • MAXN N/A
  • Fundamental
  • Price
  • ECOR $6.69
  • MAXN $2.95
  • Analyst Decision
  • ECOR Strong Buy
  • MAXN Sell
  • Analyst Count
  • ECOR 2
  • MAXN 6
  • Target Price
  • ECOR $25.50
  • MAXN $195.80
  • AVG Volume (30 Days)
  • ECOR 216.5K
  • MAXN 227.4K
  • Earning Date
  • ECOR 03-12-2025
  • MAXN 05-29-2025
  • Dividend Yield
  • ECOR N/A
  • MAXN N/A
  • EPS Growth
  • ECOR N/A
  • MAXN N/A
  • EPS
  • ECOR N/A
  • MAXN N/A
  • Revenue
  • ECOR $25,182,000.00
  • MAXN $689,010,000.00
  • Revenue This Year
  • ECOR $40.88
  • MAXN N/A
  • Revenue Next Year
  • ECOR $48.01
  • MAXN $34.68
  • P/E Ratio
  • ECOR N/A
  • MAXN N/A
  • Revenue Growth
  • ECOR 57.09
  • MAXN N/A
  • 52 Week Low
  • ECOR $5.32
  • MAXN $2.68
  • 52 Week High
  • ECOR $19.49
  • MAXN $410.00
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 19.00
  • MAXN 33.30
  • Support Level
  • ECOR $6.57
  • MAXN $3.04
  • Resistance Level
  • ECOR $8.25
  • MAXN $4.26
  • Average True Range (ATR)
  • ECOR 0.92
  • MAXN 0.36
  • MACD
  • ECOR -0.15
  • MAXN 0.02
  • Stochastic Oscillator
  • ECOR 4.82
  • MAXN 12.38

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: